Insider Purchases: Inside the Buy

Tag: hub-hedge

Illustration of a stylized crown hovering above biotech molecules and financial charts, representing XOMA Royalty’s strategy of collecting biotech royalties without developing drugs.

Can XOMA Become Royalty? The CEO, BVF Partners, and Morgan Stanley Think So!

XOMA Royalty doesn’t run clinical trials—it collects royalties. With a $2.5M CEO insider buy, heavyweight institutional backing, and improving cash flow, this biotech quiet achiever may be turning into something… royal.

Read entire article

Tags: Biotech Royalties, Biotech Stocks, buy-or-sell-XOMA, CEO buy, CEO Buys, CEO Conviction, CEO insider buying, CEO Insider Purchases, CEO Stock Purchase, CEOBuyIn, CEOConfidence, featured-insiders, funanc1al edge, funanc1al humor, FUNanc1al Investing, FUNstock Income + Growth, Healthcare Investing, hub-diversify, hub-epiphany, hub-fun, hub-hedge, hub-insiders, hub-ipos, hub-overseas, hub-ridiculous, hub-special-files, hub-value, Insider Buying, risks-investing-in-xoma, Royalty Stocks, Small-Cap Stocks, why-buy-xoma, XOMA, XOMA Royalty
Colorful illustration of a Chipotle burrito wrapped in foil with dollar signs and stock charts bursting out, symbolizing CMG stock as both food and investment.

Bill Ackman's Pershing Square Still Owns Shares; A Director Bought Much Higher: Should You Go Long Chipotle (CMG) Or Just Eat the Burritos?

Chipotle Mexican Grill (CMG) stock has been cut in half from its highs, but institutions still love it and Bill Ackman still owns a big stake. Should you wrap CMG in your portfolio—or just stick to wrapping burritos?

 

Read entire article

Tags: BillAckman, Chipotle, CMG, contrarian investing, Contrarian Play, Contrarian Stocks, Director Insider Buying, FastCasual, Funanc1al, Funanc1al Investing, Funanc1alEdge, GARP, hub-hedge, hub-insiders, Investing, Restaurants, StocksToWatch